Legal Representation
Attorney
Jason M. Rhodes
USPTO Deadlines
Application History
16 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 28, 2026 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 28, 2026 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 28, 2026 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 28, 2026 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Dec 28, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 28, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 28, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Sep 30, 2025 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Sep 30, 2025 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Jun 30, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jun 30, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jun 30, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 25, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Feb 19, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Feb 19, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Feb 19, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medicated vaginal hormone preparation for treatment of perimenopause, menopause, endometriosis, Polycystic Ovary Syndrome (PCOS), cysts, fibroids, and Premenstrual Dysphoric Disorder (PMDD) available only by prescription issued by a licensed physician; medicated, bio-identical estradiol and progesterone hormone replacement therapy preparation in the form of a vaginal cream available only by prescription issued by a licensed physician
First Use Anywhere:
Feb 1, 2024
First Use in Commerce:
Feb 1, 2024
Class 044
Provision of online and telehealth medical services by licensed physicians for women, namely, medical and pharmaceutical consultation, clinical evaluation, and prescription management concerning hormone replacement and peptide therapies and treatments; provision of health care and medical services by health care professionals via the Internet or telecommunication networks.
First Use Anywhere:
Feb 1, 2024
First Use in Commerce:
Feb 1, 2024
Classification
International Classes
005
044